← Eichor
Study identifier: NCT05796973 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Measuring Oncological Value of Exercise and Statin

Condition: Prostate Cancer · Breast Cancer · Kidney Cancer  ·  Sponsor: Tampere University Hospital

PhasePhase 3
Planned participants240
Who can joinAll sexes, 18 Years to 99 Years
Healthy volunteersNo

About this study

The aim of the study is to find out whether supervised physical exercise during cancer drug treatment improves the effectiveness of the treatment in metastasized breast, kidney, ovarian and prostate cancer compared to unsupervised exercise. In addition, the investigators are investigating whether the use of atorvastatin combined with guided group exercise training would further improve the response to cancer treatment.

This description comes directly from the study's public registry record.

Talk to the study team

Teemu Murtola, MD PhD Prof  ·  03-311611  ·  teemu.murtola@tuni.fi

Jorma Sormunen, MD PhD MBA  ·  0505001869  ·  jorma.sormunen@fimnet.fi

Always discuss trial participation with your own doctor first.

Locations (1)

Tampere University HospitalTampere, Länsi-Suomi, FinlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05796973